Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1421 |
Aceclofenac
醋氯芬酸,Preservex,Airtal |
COX | Immunology/Inflammation; Neuroscience |
Aceclofenac (Preservex) 是一种可口服的非甾体抗炎药,可用于缓解疼痛、骨关节炎、强直性脊柱炎、类风湿性关节炎的研究。 | |||
T1432 |
Phenylbutazone
Butazolidine,保泰松 |
COX | Immunology/Inflammation; Neuroscience |
Phenylbutazone (Butazolidine) 是是非甾体类抗炎药,前列腺素 H 合酶过氧化物酶的还原辅助因子,可诱导肌肉盲样蛋白 1 表达,有用于强直性脊柱炎的研究潜力。 | |||
T6668 |
SGC-CBP30
|
Epigenetic Reader Domain; Histone Acetyltransferase | Chromatin/Epigenetic |
SGC-CBP30 是高选择性CBP/p300溴结构域的有效抑制剂,对CBP 和p300的Kd 值分别为 21 和 32 nM。它强烈减少 Th17 细胞中 IL-17A 的分泌,具有抗炎作用。 | |||
T0859 |
Fenbufen
芬布芬,CL-82204,Lederfen |
ATPase; Caspase; COX | Apoptosis; Immunology/Inflammation; Membrane transporter/Ion channel; Neuroscience; Proteases/Proteasome |
Fenbufen (Lederfen) 是一种非甾体抗炎药,主要用于治疗骨关节炎、强直性脊柱炎和肌腱炎的炎症。它还可用于缓解背痛、扭伤和骨折,具有 caspases 的抑制活性。它对 COX-1和 COX-2具有抑制活性,其 IC50分别为 3.9 μM 和 8.1 μM。 | |||
T26710 |
Azapropazone
DuP-141,NSC-102824,AHR-3018,AHR 3018,MI-85 |
||
Azapropazone is anti-inflammatory agent. Azapropazone has uricosuric properties used to treat rheumatoid arthritis and ankylosing spondylitis. Azapropazone lowered plasma uric acid but exerted only a modest and variable uricosuric effect without altering | |||
T40106 | IL-17 modulator 1 | ||
IL-17 modulator 1 is an orally active small molecule. It is highly efficacious in modulating IL-17 and can effectively prevent, treat, or ameliorate various diseases such as psoriasis, ankylosing spondylitis, and psoriatic arthritis. | |||
T77098 | Netakimab | ||
Netakimab为抗IL-17单克隆抗体。Nerelimomab适用于研究强直性脊柱炎、银屑病关节炎及中重度斑块状银屑病。 | |||
T36525 |
IL-17 modulator 1 disodium
|
||
IL-17 Modulator 1 (disodium) is a potent, orally active compound, known for its high efficacy in modulating IL-17. This compound is extensively utilized for researching various diseases such as psoriasis, ankylosing spondylitis, and psoriatic arthritis[1]. | |||
T72653 |
(R)-Elsubrutinib
(R)-ABBV-105 |
||
(R)-Elsubrutinib ((R)-ABBV-105) 是一种Btk 抑制剂。(R)-Elsubrutinib 可用于免疫性疾病 (如类风湿性关节炎、银屑病、强直性脊柱炎、哮喘和系统性红斑狼疮) 和癌症的研究。 | |||
T77030 | Gumokimab | ||
Gumokimab (AK 111) 是靶向IL-17A 的单克隆抗体,可用于银屑病、强直性脊柱炎的研究。Gumokimab 能够竞争性阻断人IL-17A 与IL-17R 的结合。 | |||
T76840 | Vunakizumab | ||
Vunakizumab (Anti-Human IL17A Recombinant Antibody) 是一种重组的人源化 IgGκ 单克隆抗体,可以靶向 IL-17A 并抑制其与 IL-17受体的相互作用。Vunakizumab 可用于研究银屑病关节炎、强直性脊柱炎、多发性硬化症和炎症性关节炎等自身免疫性疾病。 |